Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 23 July 2009, doi:10.1136/bmj.b2787
Cite this as: BMJ 2009;339:b2787
C James, specialist registrar in paediatric intensive care 1, A Gupta, specialist registrar in paediatric intensive care 1, D Cheng, specialist registrar in paediatric oncology2, S Padley, specialist registrar in radiology3, N Goulden, consultant in paediatric oncology 2, S Skellett, consultant in paediatric intensive care 1
1 Paediatric Intensive Care Unit, Great Ormond Street Hospital, London WC1N 3JH, 2 Department of Haematology, Great Ormond Street Hospital, London WC1N 3JH, 3 Department of Radiology, Royal Brompton Hospital, London SW3 6NP
Correspondence to: C James chrisjames{at}doctors.org.uk
An 8 year old boy of Indian origin presented to his local hospital with a three week history of worsening respiratory symptoms. He was previously fit and well, had not been febrile, and his only medical history was a recent visit to his general practitioner because he "found it hard to catch his breath at night." He was becoming increasingly scared of going to bed at night and his mother was also concerned about some bumps that she could feel on his scalp while stroking his head in bed.
A chest radiograph was performed (fig 1
).
|
The patient was transferred to his regional paediatric intensive care unit for further investigation and management.
Blood tests were undertaken and his initial blood results were as follows (normal ranges in brackets):
Short answers
Long answers
1 Radiographic signs and differential diagnosis
The initial radiograph showed complete opacification of the right hemithorax and a mass effect. Emergency bronchoscopy revealed complete collapse of the right main bronchus. The left bronchus was partially collapsed and was intubated. The patients subsequent chest radiograph is shown in fig 2
.
|
|
2 Further investigations
Although biopsy under general anaesthetic has the highest yield in establishing a diagnosis, there is plenty of evidence stating that the administration of a general anaesthetic to a child with an anterior mediastinal mass can lead to respiratory or circulatory collapse, even in children without symptoms.2 3 4 5 If at all possible, diagnosis should be made using the least invasive investigations and avoiding a general anaesthetic. Diagnostic investigations that do not require a general anaesthetic include: 1) peripheral blood film for T cell acute lymphoblastic leukaemia; and 2) pleural tap under local anaesthetic (if pleural effusion present and the child can tolerate the procedure) for T cell lymphoblastic lymphoma.
If a diagnosis cannot be made with these investigations, the oncology team together with the anaesthesia team will need to carefully assess the risk versus benefit in performing biopsy under a general anaesthetic. In addition, the parents of the patient should be fully informed of the risks.
In this patient, the peripheral blood film showed the presence of lymphoblasts. The pleural fluid suspension was also packed with lymphoid blast cells. Immunophenotyping of these cells confirmed the diagnosis of T cell lymphoblastic malignancy. T cell lymphoblastic lymphoma is a relatively rare condition—the incidence in the United Kingdom is approximately 1-2 new cases per million population.6 It is important, therefore, that children with a large anterior mediastinal mass are referred early to a paediatric oncology centre with experience and expertise in the management of lymphoid malignancies.
3 Emergency treatment
Children presenting with large superior anterior mediastinal masses represent a medical emergency. Such children are at extremely high risk of tracheal compression leading to respiratory or circulatory compromise.2 4 5 To minimise the risk of cardiopulmonary arrest, initiating basic airway management—such as sitting the patient upright and avoiding causing unnecessary distress to the patient—is critically important. If such patients do lose their airway, turning them to the prone position might be life saving as the weight of the mass is lifted off the airway, making intubation and ventilation possible.
The treatment developed by the Berlin-Frankfurt-Münster group has the best results for children with T cell lymphoblastic lymphoma. This regimen involves a steroid pre-phase followed by combination chemotherapy for two years. The five year event free survival rate is in the region of 90%.7 The United Kingdom has now adopted a chemotherapy treatment protocol based on the Berlin-Frankfurt-Münster strategy.
Patients with T cell lymphoblastic lymphoma are at high risk for tumour lysis syndrome, which is the most common acute complication after initiation of steroid treatment. Management focuses on prevention with intravenous rasburicase and hyperhydration.8 Rasburicase is a recombinant urate oxidase and might cause allergic reactions and haemolytic anaemia in patients with glucose-6-phosphate dehydrogenase deficiency. Rasburicase is, however, a more effective treatment option than allopurinol—another drug used to treat hyperuricemia. In a multicentre randomised trial comparing rasburicase with oral allopurinol in children at high risk of tumour lysis syndrome, the plasma uric acid levels decreased by 86% within four hours of the first dose in the rasburicase group versus 12% in allopurinol group (P<0.0001).9 There was also significant reduction in creatinine levels in the rasburicase group.
Patient outcome
The patient described is presently completing his treatment as an outpatient.
Conclusion
Children with T cell lymphoblastic malignancies have an excellent long term prognosis; therefore, it is critically important to manage these children appropriately from the time of initial presentation in order to reduce the risk of avoidable morbidity and mortality.
Cite this as: BMJ 2009;339:b2787
Provenance and peer review: Unsolicited; externally peer reviewed.